<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Best Practices in Drug and Biological Product Postmarket Safety Surveillance for Food and Drug Administration Staff; Draft Document; Reopening of Comment Period</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Best Practices in Drug and Biological Product Postmarket Safety Surveillance for Food and Drug Administration Staff; Draft Document; Reopening of Comment Period</h1>
    <p class="timestamp">Published: 2020-03-06 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the notice entitled "Best Practices in Drug and Biological Product Postmarket Safety Surveillance for FDA Staff; Draft Document; Availability; Establishment of Public Docket; Request for Comments" that appeared in the Federal Register of November 7, 2019. The Agency is taking this action to allow interested persons additional time to submit comments.</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2020-04591</p>
    <p><strong>Publication Date:</strong> 2020-03-06</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2020/03/06/2020-04591/best-practices-in-drug-and-biological-product-postmarket-safety-surveillance-for-food-and-drug">https://www.federalregister.gov/documents/2020/03/06/2020-04591/best-practices-in-drug-and-biological-product-postmarket-safety-surveillance-for-food-and-drug</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2020-04591</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
